GlassScriptPhysician profile
Asmeen Bhatt
NPI 1770784399
$5,847.06
in general payments reported to CMS, 2019-2025
14 companies · $95.79 in 2025
The $95.79 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $41.76 · 2021: $125 · 2022: $784 · 2023: $1,656 · 2024: $2,288 · 2025: $95.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,468 · Travel and Lodging: $1,222 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,468.00 |
| Travel and Lodging | $1,221.66 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,005.88 | 2021-2024 | Apollo Esg System, Resolution Clip, Acquire |
| Apollo Endosurgery US INC | $1,000.48 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Abbvie INC. | $992.45 | 2022-2024 | Linzess, Rinvoq |
| Pentax of America, INC. | $367.94 | 2024 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Steris Corporation | $302.34 | 2023-2024 | |
| Medtronic, INC. | $275.41 | 2022-2023 | Nexpowder |
| Janssen Scientific Affairs, LLC | $243.99 | 2019-2022 | |
| Conmed Corporation | $197.45 | 2024-2025 | Conmed Generators |
| Cook Medical LLC | $96.23 | 2023 | Echotip |
| Celltrion USA INC. | $95.36 | 2023 | Yuflyma |
| Nestle Healthcare Nutrition INC. | $91.31 | 2023 | |
| Ethicon US, LLC | $86.43 | 2023 | Linx Reflux Management System |
| Endogastric Solutions, INC | $50.03 | 2022 | |
| Lumendi LLC | $41.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asmeen Bhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.